Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1999;94:431-434
© 1999 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SINGH, K.
Right arrow Articles by DONG, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SINGH, K.
Right arrow Articles by DONG, F.

ORIGINAL RESEARCH

Evacuation Interval After Vaginal Misoprostol for Preabortion Cervical Priming: A Randomized Trial

KULDIP SINGH, MD, Y. F. FONG, MRCOG, R. N. V. PRASAD, MD and F. DONG, PhD

From the Department of Obstetrics and Gynaecology, National University Hospital, Singapore and the Biostatistics Consultancy Unit, National University Hospital Medical Institute, Singapore.

Address reprint requests to: Kuldip Singh, MD Department of Obstetrics and Gynecology National University Hospital Lower Kent Ridge Road Singapore 119074 E-mail: obgkuldi{at}nus.edu.sg

Objective: To determine the optimal interval for evacuation after preabortion cervical priming with vaginal misoprostol.

Methods: One hundred eighty healthy nulliparas requesting legal termination of pregnancy between 6 and 11 weeks’ gestation were assigned randomly to receive 400, 600, or 800 µg of intravaginal misoprostol. Vacuum aspiration was done after 3 hours in the 400-µg group and after 2 hours in the 600- and 800-µg groups. The degree of cervical dilatation before operation was measured with a Hegar dilator. Preoperative and intraoperative blood loss and associated side effects were also assessed.

Results: Eleven (18.3%) and 15 (25.0%) women in the 600-and 800-µg groups, respectively, had cervical dilatation of at least 8 mm after an interval of 2 hours; 55 (91.7%) women who received 400 µg for a 3-hour interval had similar cervical dilatation. Using 400 µg as a baseline, the odds ratio (OR) was 0.02; 95% confidence interval (CI) was 0.01, 0.06 for 600 µg and OR 0.03; 95% CI 0.01, 0.09 for 800 µg for achieving successful preabortion cervical dilatation of at least 8 mm. The mean cervical dilatation of 6.7 mm and 6.8 mm for the higher doses was also significantly less than that of 8.1 for the 400-µg dose (P < .001). The mean preoperative and intraoperative blood loss was only statistically different when the 400- and 800-µg groups were compared (P = .03). There were also significantly more side effects, namely abdominal pain and fever above 38.0C, in the 600- and 800-µg groups (P < .001), compared with the 400-µg group. When the 600- and 800-µg groups were compared, there were still significantly more women complaining of abdominal pain (P < .001). None of the women in the study required analgesics for pain or antipyretics for fever.

Conclusion: The minimal evacuation interval should be at least 3 hours for successful preabortion cervical priming.




This article has been cited by other articles:


Home page
Hum ReprodHome page
O. S. Tang, K. H. Mok, and P. C. Ho
A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester
Hum. Reprod., May 1, 2004; 19(5): 1101 - 1104.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
E. Ekerhovd, N. Radulovic, and A. Norstrom
Gemeprost Versus Misoprostol for Cervical Priming Before First-Trimester Abortion: A Randomized Controlled Trial
Obstet. Gynecol., April 1, 2003; 101(4): 722 - 725.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
K. Blanchard, S. Clark, B. Winikoff, G. Gaines, G. Kabani, and C. Shannon
Misoprostol for Women's Health: A Review
Obstet. Gynecol., February 1, 2002; 99(2): 316 - 332.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. B. Goldberg, M. B. Greenberg, and P. D. Darney
Misoprostol and Pregnancy
N. Engl. J. Med., January 4, 2001; 344(1): 38 - 47.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Obstetricians and Gynecologists.